Cyclopharm’s record year for radiopharmaceuticals
Radiopharmaceutical producer Cyclopharm has announced record sales revenue for 1H FY23 of $15.3 million, up 39 percent on the previous corresponding period. Sales of its Technegas product were steady on the previous corresponding period, with third party distribution sales up 116 percent on the PCP to $7.7 million. For the first time third party sales…